Genomics BioSci & Tech. Co.,Ltd.

Research Genomics BioSci & Tech. Co.,Ltd. (4195.TW) on Bullrun: market cap TWD 1.26B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker4195.TW
ExchangeTW
CountryTaiwan
SectorHealthcare
IndustryBiotechnology
CurrencyTWD
Market capTWD 1.26B
Financial periodQ2 2026
RevenueTWD 168.30M
Net incomeTWD 28.68M
Free cash flow-TWD 16.46M
Gross margin22.8%

Valuation Snapshot

latest market cap is TWD 1.26B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	TWD 1.26B	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 TWD.

About Genomics BioSci & Tech. Co.,Ltd.

Genomics BioSci & Tech. Co.,Ltd. operates as a genomic company in Taiwan. The company offers sequencing, synthesis, genomic, proteomic, and agency and sales services; clinical testing services, such as reproductive health and cancer testing services; and contract development and manufacturing services. The company was founded in 2001 and is based in New Taipei City, Taiwan.

Related stock research

Taiwan stocks Taiwan Healthcare stocks A-Z stock index

Other Healthcare stocks

Synbio Tech Inc. (1295.TWO) Sinphar Pharmaceutical Co.,Ltd. (1734.TW) Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO) Level Biotechnology Inc. (3118.TWO) GenMont Biotech Incorporation (3164.TW) Medigen Biotechnology Corp. (3176.TWO) Sagittarius Life Science Corp (3205.TWO) NeoCore Technology Co., Ltd. (4131.TWO) Abnova (Taiwan) Corporation (4133.TW) Adimmune Corporation (4142.TW) TaiMed Biologics Inc. (4147.TWO)

Frequently asked questions

What is Genomics BioSci & Tech. Co.,Ltd.'s market cap?

Genomics BioSci & Tech. Co.,Ltd.'s market capitalization is TWD 1.26B.